Heart rate in hypertensive patients treated with ACE inhibitors and long-acting dihydropyridine calcium antagonists

被引:5
|
作者
Pierdomenico, SD [1 ]
Bucci, A [1 ]
Lapenna, D [1 ]
Cuccurullo, F [1 ]
Mezzetti, A [1 ]
机构
[1] Univ G DAnnunzio, Dipartimento Med & Sci Invecchiamento, Dislipidemie & Arteriosclerosi, Ctr Studio Ipertens Arteriosa, Chieti, Italy
关键词
drug therapy; heart rate; hypertension;
D O I
10.1097/00005344-200208000-00014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rapid heart rate (HR) has been reported to be a predictor of cardiovascular morbidity and mortality in hypertensive patients, The aim of this study was to evaluate the effect of ACE inhibitors and long-acting dihydropyridine calcium antagonists on clinic and ambulatory HR in patients with essential hypertension. We selected 292 hypertensive patients treated with ACE inhibitors and 198 hypertensive patients treated with dihydropyridine calcium antagonists. Groups were balanced for age, gender, body mass index, baseline blood pressure (BP) and HR. treatment duration and occupation. Patients had been submitted to clinic evaluation and noninvasive monitoring of BP and HR at baseline and during chronic therapy. Clinic and ambulatory BP were significantly and similarly reduced in patients treated with ACE inhibitors and calcium antagonists. Globally, clinic and 24-h HR were significantly reduced in patients treated with ACE inhibitors and remained unchanged in those treated with calcium antagonists, When patients were grouped according to baseline clinic HR (< 65 beats/min 65-74 beats/min, 75-84 beats/min, and >85 beats/min), ACE inhibitors did not significantly change HR in subjects with baseline clinic HR <74 beats/min but significantly reduced clinic, 24-h, daytime and nighttime HR in those with baseline HR >75 beats/min and particularly in those with baseline HR >85 beats/min, Calcium antagonists did not significantly change clinic, 24-h, daytime and nighttime HR in various subgroups. Our study shows that ACE inhibitors reduce both clinic and ambulatory HR in hypertensive patients with faster HR, who seem to be at higher risk, and that long-acting dihydropyridine calcium antagonists do not induce significant changes in HR during chronic treatment (neither decrease nor increase). Whether this aspect is associated with I better prognostic impact of ACE inhibitors in essential hypertension should be determined in prospective studies.
引用
收藏
页码:288 / 295
页数:8
相关论文
共 50 条
  • [1] Heart rate in hypertensive patients treated with ace-inhibitors and calcium antagonists
    Pierdomenico, SD
    Bucci, A
    Costantini, F
    Lapenna, D
    Cuccurullo, F
    Mezzetti, A
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S18 - S18
  • [2] Heart rate in hypertensive patients treated with ACE-inhibitors and calcium antagonists
    Pierdomenico, S
    Bucci, A
    Lapenna, D
    Cuccurullo, F
    Mezzetti, A
    [J]. JOURNAL OF HYPERTENSION, 2000, 18 : S51 - S52
  • [3] Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients
    Kloner, RA
    Vetrovec, GW
    Materson, BJ
    Levenstein, M
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (02): : 163 - 169
  • [4] Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients
    Alderman, MH
    Cohen, H
    Roque, R
    Madhavan, S
    [J]. LANCET, 1997, 349 (9052): : 594 - 598
  • [5] Calcium antagonists, ACE inhibitors, and the risk of cancer in hypertensive patients
    E Grossman
    FH Messerli
    [J]. Journal of Human Hypertension, 2000, 14 : 285 - 286
  • [6] Calcium antagonists, ACE inhibitors, and the risk of cancer in hypertensive patients
    Grossman, E
    Messerli, FH
    [J]. JOURNAL OF HUMAN HYPERTENSION, 2000, 14 (05) : 285 - 286
  • [7] Heart rate variability in patients with hypertension and type 2 diabetes treated with long acting calcium antagonists
    Lopatin, YM
    Kirakozov, DA
    Statsenko, ME
    [J]. KARDIOLOGIYA, 2003, 43 (05) : 33 - 36
  • [8] Place of calcium antagonists in combination with ACE inhibitors in risk management of hypertensive patients
    Holzgreve, H
    [J]. PERFUSION, 1998, 11 (05): : 232 - 233
  • [9] Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists
    Bakris, GL
    Smith, A
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (03) : 201 - 204